Why the study?
Does targeted radiofrequency ablation modulate gastric bioelectrical activation in an anesthetized pig model?
Does targeted radiofrequency ablation modulate gastric bioelectrical activation in an anesthetized pig model?
Targeted radiofrequency ablation can successfully eliminate gastric pacemaker sites without damaging surrounding tissue, offering a potential tool for treating gastric dysrhythmias.
May enable gastric dysrhythmia therapy in preclinical models; leaves open translation to human efficacy and safety.
This study presents gastric ablation as a novel tool for modulating gastric bioelectrical activation, including eliminating the normal gastric pacemaker site as well as abnormal ectopic pacemaker sites underlying gastric dysrhythmias. Targeted application of radiofrequency ablation was able to eliminate these pacemaker sites without disrupting surrounding conduction capability or tissue structure. Gastric ablation presents a powerful new research tool for modulating gastric electrical activation and may likely hold therapeutic potential for disorders of gastric function.
No takes yet. Share an insight, caveat, or question.
Aghababaie et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: